Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
CNS & Neurological Disorders Drug Targets|June 3, 2011
Fatty acid amide hydrolase inhibitors--progress and potentialIsh K Khanna, Christopher W AlexanderJournal of Pain Research|December 18, 2015
Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic painIsh K Khanna, Sivaram PillarisettiCurrent Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
Atherosclerosis -- new targets and therapeuticsSivaram Pillarisetti, Christopher W Alexander, Uday SaxenaDrug Discovery Today|September 1, 2009
Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseasesSivaram Pillarisetti, Christopher W Alexander, Ish KhannaBioorganic & Medicinal Chemistry|March 28, 2007
Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimizationSrinivasan R Nagarajan, Hwang-Fun Lu, Alan F Gasiecki, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonistsMark L Boys, Lori A Schretzman, Nizal S Chandrakumar, et al.Pageof 1